PuraPharm Corporation Limited Profile Avatar - Palmy Investing

PuraPharm Corporation Limited

PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through fi…

Drug Manufacturers - Specialty & Generic
HK, Tai Po [HQ]

Cash Flow Statements

11 Records · Starting from 2013
In Million HKD. Margins, Growth Rates In %
Metric 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
11.00 31.00 -12.00 -55.00 -42.00 72.00 101.00 86.00 -39.00 65.00 53.00
Operating Cash (Net)
11.00 31.00 -12.00 -55.00 -42.00 72.00 101.00 86.00 -39.00 65.00 53.00
Accounts Receivable
-30.00 -3.00 -59.00 -85.00 32.00 -56.00 48.00 7.00 -43.00 101.00 52.00
Accounts Payable
- - - - -6.00 40.00 14.00 30.00 44.00 -29.00 -22.00 9.00 10.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-6.00 -24.00 -44.00 -65.00 -293.00 -36.00 -75.00 -82.00 -3.00 -25.00 -22.00
Capital Expenditure
-17.00 -8.00 -28.00 -41.00 -101.00 -45.00 -96.00 -82.00 -6.00 -23.00 -21.00
Purchases of Investments
- - - - -3.00 - - -9.00 -11.00 -9.00 - - - - -1.00 - -
Sale/Maturity of Investment
- - - - 1.00 - - 170.00 11.00 - - - - - - - - - -
Property, Plant, Equipment (P&PE)
-17.00 -8.00 -28.00 -41.00 -101.00 -45.00 -96.00 -82.00 -6.00 -23.00 -21.00
Acquisitions (Net)
- - - - 1.00 - - -160.00 - - - - - - 2.00 - - - -
Other Investing Activities
10.00 -16.00 -14.00 -23.00 -20.00 9.00 30.00 -9.00 9.00 - - 4.00
Financing Activities
Used Cash (Net)
-2.00 - - -267.00 -102.00 -204.00 -28.00 -49.00 -29.00 -8.00 -12.00 -96.00
Debt Repayment
-18.00 -303.00 -52.00 -284.00 -375.00 -548.00 -18.00 -32.00 -44.00 -6.00 -73.00
Dividends Paid
- - - - - - -19.00 -4.00 - - - - - - - - - - - -
Common Stock
- - - - - - 304 - - - - - - - - - - - - - -
Other Financing Activities
-16.00 273.00 5.00 417.00 585.00 520.00 -30.00 -35.00 53.00 -6.00 -35.00
Cash Balances
Begin of Period
16.00 25.00 30.00 232.00 209.00 86.00 113.00 93.00 126.00 85.00 107.00
End of Period
25.00 30.00 232.00 209.00 86.00 90.00 93.00 126.00 85.00 107.00 47.00
Change
8.00 5.00 201.00 -23.00 -122.00 3.00 -20.00 33.00 -41.00 21.00 -59.00
Non-Cash Balances
Depreciation and Amortization
11.00 13.00 13.00 15.00 24.00 35.00 66.00 47.00 50.00 48.00 48.00
Stock Based Compensation
- - - - - - - - 2.00 2.00 4.00 5.00 3.00 - - 4.00
Other
-6.00 11.00 26.00 52.00 -22.00 16.00 165.00 64.00 276.00 51.00 73.00
Highlighted metrics
Free Cash Flow (FCF)
-6.00 22.00 -40.00 -97.00 -144.00 27.00 4.00 3.00 -45.00 42.00 32.00
Cash Conversion Cycle (CCC)
210.00 226.00 275.00 338.00 501.00 293.00 176.00 208.00 256.00 230.00 156.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of 1498.HK's Analysis
CIK: - CUSIP: G7306Y104 ISIN: KYG7306Y1044 LEI: - UEI: -
Secondary Listings
1498.HK has no secondary listings inside our databases.